Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,790,780
+$1,319,760 QoQ
Shares Held
702,000
0.0% QoQ
Ownership
0.587%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#32
of 197 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NWI MANAGEMENT LP holds $184,769,247 across 6 Biotechnology names. NAMS ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,014,000 | $108,112,680 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
180,000 | $33,710,400 | |
| 3 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
702,000 | $23,790,780 | |
| 4 | ABVX |
Abivax S.A.
|
72,000 | $9,594,720 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
241,671 | $9,352,667 | |
| 6 | ALLO |
Allogene Therapeutics, Inc.
|
100,000 | $208,000 |
All Filings in NAMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,790,780 | 702,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,471,020 | 702,000 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $24,626,160 | 702,000 | Shares | Sole | 2026-06-01 | |
| No filing history on record for this holder in this stock. | ||||||